Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Podium Finish: US FDA’s 61 Novel Approvals In 2024 Fall Short Of 2023 Peak But Exceed Average
Jan 01 2025
•
By
Bridget Silverman
The 2024 novel approval total was a top three finish.
(Shutterstock)
More from Pink Sheet Perspectives
More from Regulatory Trackers